Acceleron Pharma Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2021 to a ratio of 3.98, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the third quarter 2021. Average collection period, for Acceleron Pharma Inc's accounts receivable remained unchanged at 92 days, in the Sep 30 2021 quarter.

If we take a look into Healthcare sector 446 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2021 from 2589 to 3065.

What is Receivable Turnover Ratio?
What is Acceleron Pharma Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

XLRN Receivables Turnover Ratio	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter
Y / Y Receivable Change	51.57 %	-29.72 %	198.84 %	205.38 %	228.16 %
Y / Y Revenue Change	51.58 %	-29.71 %	469.94 %	-34.25 %	436.15 %
Receivable Turnover Ratio (TTM)	3.98	3.97	3.98	3.82	5.35
XLRN's Total Ranking	# 3065	# 2589	# 2952	# 3058	# 3065
Accounts Receivable average collection period days	92	92	92	96	68
Seq. Receivable Change	22.4 %	10.83 %	-3.43 %	15.69 %	-43.25 %
Seq. Revenue Change	22.4 %	12.85 %	-4.28 %	14.65 %	-43.25 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 41
Healthcare Sector	# 447
Overall Market	# 3065

Receivable Turnover Ratio Statistics
High	Average	Low
0.18	0.1	0.03
(Jun 30 2020)		(Mar 31 2019)

XLRN Company Profile • Back to XLRN Efficiency Comparisons • Compare XLRN Receivables Turnover Ratio to its Competitors

Financial Statements
Acceleron Pharma Inc's Accounts Receivable	$ 34 Millions	Visit XLRN's Balance sheet
Acceleron Pharma Inc's Sales TTM	$ 113 Millions	Visit XLRN's Income Statement
Sources of XLRN's Revenues		Visit XLRN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
XLRN's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
XLRN's Growth Rates	XLRN's Roa	XLRN's Inventory Turnover Ratio	XLRN's Dividend Comparisons
XLRN's Profitability Ratios	XLRN's Roi	XLRN's Asset Turnover Ratio	XLRN's Dividend Growth
XLRN's Valuation Ratios	XLRN's Roe	XLRN's Financial Strength Ratios	XLRN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2021, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2021	Receivable at quarter ending Sep 30 2021
Viemed Healthcare Inc	8.96	$ 116.302 Millions	$ 12.976 Millions
Evoke Pharma Inc	8.96	$ 1.281 Millions	$ 0.143 Millions
Becton Dickinson And Company	8.94	$ 20,248.000 Millions	$ 2,265.750 Millions
Lifeloc Technologies Inc	8.91	$ 6.890 Millions	$ 0.773 Millions
Iradimed Corporation	8.91	$ 38.488 Millions	$ 4.319 Millions
Perrigo Company Plc	8.85	$ 4,323.300 Millions	$ 488.475 Millions
Diversicare Healthcare Services Inc	8.82	$ 491.192 Millions	$ 55.680 Millions
Angiodynamics Inc	8.81	$ 297.765 Millions	$ 33.814 Millions
Silk Road Medical Inc	8.78	$ 94.343 Millions	$ 10.743 Millions
Quanterix Corporation	8.78	$ 106.400 Millions	$ 12.125 Millions
Zai Lab Limited	8.76	$ 113.126 Millions	$ 12.913 Millions
Axonics Inc	8.72	$ 161.938 Millions	$ 18.565 Millions
Adamas Pharmaceuticals Inc	8.69	$ 88.189 Millions	$ 10.153 Millions
Henry Schein Inc	8.66	$ 12,236.224 Millions	$ 1,412.790 Millions
Atricure Inc	8.61	$ 258.836 Millions	$ 30.055 Millions
Acadia Pharmaceuticals Inc	8.58	$ 474.394 Millions	$ 55.290 Millions
The Pennant Group Inc	8.57	$ 435.896 Millions	$ 50.879 Millions
Cartesian Therapeutics Inc	8.56	$ 67.091 Millions	$ 7.839 Millions
Resmed Inc	8.54	$ 4,746.857 Millions	$ 556.056 Millions
Histogen Inc	8.52	$ 2.483 Millions	$ 0.292 Millions
Idexx Laboratories Inc	8.52	$ 3,135.208 Millions	$ 368.072 Millions
Tela Bio Inc	8.50	$ 26.756 Millions	$ 3.149 Millions
Radnet Inc	8.48	$ 1,296.720 Millions	$ 152.979 Millions
Biofrontera Inc	8.47	$ 4.334 Millions	$ 0.512 Millions
Y mabs Therapeutics inc	8.46	$ 46.049 Millions	$ 5.445 Millions
Chemocentryx Inc.	8.41	$ 64.176 Millions	$ 7.635 Millions
Grapefruit Usa Inc	8.40	$ 1.679 Millions	$ 0.200 Millions
Cutera Inc	8.39	$ 215.584 Millions	$ 25.694 Millions
Invitae Corporation	8.38	$ 434.759 Millions	$ 51.865 Millions
Cytosorbents Corporation	8.38	$ 44.339 Millions	$ 5.293 Millions

Date modified: 2026-08-29T17:22:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.